Generated by AI
Revvity Inc. is a global life sciences and diagnostics company that provides health science solutions, technologies, and services for research, development, and clinical testing. Revvity’s current business is organized around two main segments: Life Sciences, which supplies reagents, instruments, and software to support biopharma and academic research; and Diagnostics, which offers assay platforms, instruments, and software for reproductive health, immunodiagnostics, newborn screening, applied genomics, and infectious disease testing. The company also focuses on translational multi-omics, biomarker identification, imaging, screening, detection, and informatics, helping customers move biological data through connected laboratory workflows. Revvity serves pharmaceutical and biotechnology companies, diagnostic laboratories, academic institutions, and government organizations across global markets. Headquartered in Waltham, Massachusetts, Revvity plays an important role in enabling scientific discovery and supporting clinical decision-making across the healthcare and research ecosystem.
Website77 4th Avenue
Waltham, MA, 02451
United States
The latest articles about RVTY.
Detailed price information for Moderna Inc (MRNA-Q) from The Globe and Mail including charting and trades.
Summary of Sep 16's posts. Generated by AI.
No summary yet.
Summary of Feb 2's posts. Generated by AI.
Summary of Feb 2's posts. Generated by AI.
Investors talking about RVTY also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.